Don't let sunburn be your summer holiday souvenir
11 November 2016
Bad sunburn in childhood increases your risk of developing potentially deadly melanoma, prompting warnings for Aussies to ensure sunburn isn’t their summer holiday souvenir.
Melanoma Institute Australia CEO Carole Renouf has issued the reminder as the festive season draws closer and families prepare to embark on their annual summer holidays.
‘The summer holidays in Australia are renowned for families enjoying long playful days in the sun, surf and sand,’ Ms Renouf said. ‘Whilst summer holidays are the perfect time to reconnect with family and friends and recharge after a busy year, they are also the prime time for severe sunburn.
‘In addition to being painful, sunburn can have a far more harmful impact. Intense, intermittent exposure leading to sunburn at a young age significantly increases your risk of developing melanoma in the future,’ she said.
One Australian dies from melanoma every six hours. Melanoma is the most common cancer affecting 15-39 year-old Australians and the leading cause of cancer death in 20-39 year-olds. The incidence of melanoma in the over 60s is also high, a legacy of sun-damage from decades ago.
Ultraviolet (UV) radiation is damaging to skin cells as it causes mutations in DNA and it also impairs the immune system’s ability to repair. Intense, intermittent sun exposure leading to sunburn – particularly in the years prior to puberty – is the most dangerous. Melanoma can develop decades after such exposure.
The real tragedy of melanoma is that it is largely preventable. Sunscreen acts as a barrier, reducing the amount of UV radiation that reaches cells. However, the active ingredients in sunscreen break down quickly, meaning a single application in the morning will not last the whole day. It needs to be reapplied at least every two hours and it needs to be SPF50+.
‘People relaxing on holidays tend to get sun-safe before they head out in the morning, but then get caught up in the day’s activities and forget the basics like covering up and staying out of the sun during hottest part of the day,’ Ms Renouf said.
‘I urge holiday-makers to not become complacent and actively take steps to help protect against the serious risks posed by just one bad case of sunburn, particularly to children and adolescents.
‘And when you arrive home is a perfect time to check your skin for any changes. You need to get to know the skin you’re in and ask family and friends to check places you can’t easily see.
‘There are far better souvenirs to bring back from a summer holiday than a bad sunburn, which has the potential for serious ramifications,’ she said.
Summer holiday check list
- Apply and re-apply SPF 50+ sunscreen
- Wear a broad-brimmed hat, sunglasses and cover up
- Stay out of the sun during the hottest part of the day
- Get to ‘know the skin you’re in’, and ask family members or friends to check for skin changes in places you can’t see, as melanoma is most common in men on the back and in women on the calves.
- Opt for a keyring or fridge magnet as your summer holiday souvenir, don’t bring sunburn home with you
Clinical research undertaken at MIA has been pivotal in supporting the recent Therapeutic Goods Administration approval of Opdivo (nivolumab) for advanced melanoma.
Maddison, the face of our Melanoma March campaign, knows the far-reaching effects that melanoma can have.
MIA's Dermatologist Associate Professor Pascale Guitera answers your most commonly-asked questions about sunscreen.
Statistics released by the Queensland Cancer Registry have revealed that melanoma is the most common cancer in young Queenslanders aged under 35, with rates in young women more than 20 per cent higher than in men.
As 2015 draws to a close, we took the opportunity to speak with Associate Professor Georgina Long to discuss her crucial role at Melanoma Institute Australia, and the current research projects she is working on.
MIA’s annual summer awareness campaign, which launched today (1 December), is reminding Australians how to protect themselves from the sun while highlighting the importance of encouraging friends, partners and family to do the same.
Your Guide to Early Melanoma is a new patient information pack to offer additional information for those affected by melanoma.
Special Event to share advances in diagnosis and treatment of both early and late stage melanoma
MIA researchers contribute to the discovery of ‘treasure trove’ of information leading to more targeted treatments for melanoma
Melanoma Institute Australia (MIA) patient Tara Moran and her seven year old daughter Olivia, who is fundraising for MIA, have been in the national media spotlight this week.
Melanoma Institute Australia’s (MIA’s) researchers have again been recognised, this time in the prestigious line-up for the 2015 Thomson Reuters Australian Citation & Innovation Awards.
New Federal Government funding means patients with the most deadly form of melanoma, will soon be able to receive treatment with the drug Keytruda® (pembrolizumab), on the Pharmaceutical Benefits Scheme (PBS).
The best ever results seen in metastatic melanoma treatment have been presented at the International ASCO Conference.
We sat down for a short Q&A with our Clinical Research Fellow Sangeetha Ramanujam.
Today marks International Clinical Trials Day held on May 20 each year celebrating how far clinicians have come in the field of research.
We sat down with MIA Practice Manager, Sherrie D'Souza and got an insight into the day of life of her role.
Dr Long was nomitated for the InStyle Women In Style Awards in the Science and Environment category.
The Federal Government’s 2015-16 Budget was announced this week with a boost for medical research funding.
The Association's members include prominent surgeons from around the world.
MIA leads the world-first study that finds anti–PD-1 antibody pembrolizumab increases the survival of patients
This is a landmark study, the first in a class of drugs that will change the future of treatment for all cancers.